JILLIAN JOHNSON: Open Payments
NPI 1336841881 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,010 in 142 payments from 41 companies in 2025. Trend: 2023 $915 · 2024 $2,696 · 2025 $4,010
Food & beverage: $2,731Long term medical supply or device loan: $1,180Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 28 | $1,461 |
| Janssen Biotech, Inc. | 16 | $401 |
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| PharmaEssentia USA Corporation | 3 | $168 |
| Stemline Therapeutics Inc. | 5 | $160 |
| GENZYME CORPORATION | 4 | $111 |
| PFIZER INC. | 8 | $87 |
| Celgene Corporation | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Regeneron Healthcare Solutions, Inc. | 4 | $78 |
Products named: KISQALI, BESREMI, Orserdu, ERLEADA, IMFINZI, RYBREVANT, PLUVICTO, TECVAYLI.
Industry payments across AL — which companies pay providers there.
